The largest database of trusted experimental protocols

8 protocols using helios 22f6

1

Comprehensive Antibody Panel for T-Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used from eBioscience (San Diego, CA) unless otherwise specified: Helios (22F6; Biolegend, San Diego, CA), CD90.1 (H1S51), TCRβ (H57-597; BD Biosciences, San Jose, CA), CD69 (H1.2F3), Vβ5 (MR9-4; BD Biosciences), Foxp3 (FJK16S), CD45RB (C363.16A), CD45.1 (A20), Vα2 (B20.1), CD3ε (eBio500A2), CD152 (UC10-4B9), folate receptor 4 (eBio12A5), CD73 (eBioTY/11.8), Vα2 (B20.1; BD Biosciences), CD25 (PC61.5), and CD4 (RM4-5; BD Biosciences).
+ Open protocol
+ Expand
2

T Cell Activation and Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD3 (145–2C11), anti-CD28 (37.51), and anti-mouse CD16/CD32 (2.4G2) were purchased from BioXCell. Flow cytometry antibodies against CD4 (RM4–5), CD69 (H1.2F3), Nur77 (12.14), CD25 (PC61.5), and PD-1 (J43) were from eBioscience, against CD8α (53–6.7) and TCRβ (H57) from BD Pharmingen, and against Helios (22F6) from BioLegend. Live/dead fixable blue dead cell stain was from Invitrogen. Immunoblotting, antibodies against Nur77 (12.14), Helios (D8W4X), and β-Actin (AC-15) were from eBioscience, Cell Signaling, and Sigma, respectively. PE-conjugated α-galactosylceramide-loaded mouse CD1d tetramer was obtained from the NIH tetramer core facility.
+ Open protocol
+ Expand
3

Cytokine and Transcription Factor Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines, transcriptional factors and surface markers were evaluated by flow cytometry with a FACSCanto II (BD Biosciences). To detect intracellular expression of IL-17A, IFN-γ in CD4+ T cells, lymph nodes or CNS (purified with Percoll) were first treated with 750 ng ml−1 ionomycin (Sigma), 50 ng ml−1 phorbol 12-myristate 13-acetate (PMA) (Sigma) and GolgiPlug (BD Biosciences) for 4–6 h at 37 °C. Cells were fixed and permeabilized with the Foxp3 Staining Buffer Set (eBioscience) or BD Cytofix/Cytoperm (BD Biosciences) and were stained with fluorescent antibodies. After washing, stained cells were assayed with a BD Biosciences FACSCanto II flow cytometer and data were analysed with FlowJo software. For flow cytometry, monoclonal antibodies against CD4 (clone GK1.5), CD8 (clone 53-6.7), CD62L (clone MEL-14), CD44 (clone IM7), CD25 (clone PC61.5), IL-17A (clone eBio17B7), IFN-γ (clone XMG1.2), Helios (22F6, Biolegend) and FoxP3 (clone FJK-16s) were from eBioscience and CD3 (clone 145-2C11) was from Biolegend.
+ Open protocol
+ Expand
4

Multiparametric Analysis of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
We stained human PBMCs with monoclonal antibodies to CD3 (UCHT1; BD Biosciences), CD4 (SK3; BD Biosciences), CD8 (SK1; BD Biosciences), CD25 (M-A251; BD Biosciences), CD45RA (ALB11; Beckman Coulter), CCR7 (MAB197; R&D Systems), Helios (22F6; BioLegend), Foxp3 (236A/E7; eBioscience), IL4 (MP4-25D2; BD Biosciences), IL-17 (eBio64DEC17; eBioscience), IFN-γ (B27; BD Biosciences) and a Fixable Viability Dye eFluor780 (eBioscience). The cytokine-producing capacity of T cell subsets was assessed after PBMCs were stimulated (at a density of 5 × 105 cells per 100 μL) for 5 h with 50 ng/ml PMA (phorbol 12-myristate 13-acetate; Sigma-Aldrich) and 2 mg/ml of ionomycin (Sigma-Aldrich) in the presence of 10 mg/ml of brefeldin A (Sigma-Aldrich). Cells were fixed and made permeable with the Foxp3/Transcription Factor Staining Buffer Set according to the manufacturer's instructions (eBioscience). For flow cytometric analysis of human intestine, IEL and LPL were stained with monoclonal antibodies to CD3 (UCHT1; BD Biosciences), CD4 (SK3; BD Biosciences), CD8 (SK1; BD Biosciences), IL-7Rα (HIL-7R-M21; BD Pharmingen), and c-Kit (104D2; BD Biosciences).
+ Open protocol
+ Expand
5

Multiparametric Flow Cytometry for Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were analyzed using Aurora (Cytek) and LSR Fortessa (Becton Dickinson) flow cytometers and the resulting data were analyzed using FlowJo software (Tree Star, Inc). The following monoclonal antibodies were used from eBioscience, CD3ε (145-2C11); CD4 (GK1.5); CD8a (53-6.7); CD45 (30-F11); Foxp3 (FJK-16s). Helios (22F6) and Ki67 (16A8) were from Biolegend. GITR was from BD. Nrp1 was purchased from R&D Systems.
+ Open protocol
+ Expand
6

T Cell Phenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface staining, fluorophore-conjugated monoclonal Abs (mAbs) specific for CD3ε(17A2), TCRβ(H57–597), CD4(GK1.5 or RM4–5), PD-1 (RMP1–30), GITR (DTA-1), and CTLA-4 (UC10–4B9) were obtained from BioLegend. The mAb recognizing CXCR5 (2G8) was from BD Pharmingen. The mAb recognizing TCR Vβ6(RR4–7) was from eBioscience. For intranuclear staining, buffers from a Foxp3 Staining Buffer Set (eBioscience) were used to stain with Abs recognizing Foxp3 (FJK-16s, eBioscience), Helios (22F6, Biolegend), and/or Nur77 (12.14, eBioscience). Cells were run on an LSRII (BD Biosciences), and analyses were performed with FlowJo (TreeStar) software.
+ Open protocol
+ Expand
7

Comprehensive T cell phenotyping and analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following anti-mouse fluorochrome-conjugated mAbs and their respective isotype controls were used: CD3 (145-2C11), CD4 (clone RM4-5), CD8 (53-6.7), CD44 (IM7), CD49d (DX5), CD62L (MEL-14), B220 (RA3-6B2), IL-2 (JES6-5H4), IFN-γ (XMG1.2), IL-10 (JES5-16E3), IL-17 (TC11-18H10), MHC class II (I-A/I-E), PD-1 (CD279), all purchased from BD Biosciences; Helios (22F6) from Biolegend; and CD25 (PC61) and Foxp3 (FJK-16s) from eBioscience. For the detection of cytokines, cells from spleen and LN were resuspended at approximately 4 × 106 cells/ml in RPMI-10% FCS, restimulated with 50 ng/ml phorbol 12-myristate 13-acetate (PMA) and 0.5 µg/ml ionomycin for 5 h, in the presence of 10 µg/ml Brefeldin A (Sigma). Cells were then harvested, surface stained, fixed for 10 min in BD FACS Lysing Solution (BD Biosciences), and washed and permeabilized with PermBuffer (eBioscience) before intracellular staining. Intracellular Foxp3 staining was performed using a Foxp3 staining kit (eBioscience). The staining of antigen-specific CD4+ T cells was carried out using the MHC class II I-Ab HY (116-130) NAGFNSNRANSSRSS tetramer (TCMetrix, Epalinges, Switzerland). Flow cytometry acquisition was done on FACS-Calibur™ using CellQuest™ (BectonDickinson) and data analyzed using FlowJo 9.5.3 software (Treestar).
+ Open protocol
+ Expand
8

Transcription Factor and Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transcription factor staining, cells were treated as above then fixed and permeabilized with the eBioscience™ Intracellular Fixation and Permeabilization Buffer Set (Invitrogen) and incubated with fluorochrome-conjugated antibodies against FOXP3 (150D/E4; Thermo Fisher), active-Caspase-3 (C92-605; BD Pharmagen), Ki67 (16A8; BioLegend), Helios (22F6; BioLegend). For intra-cellular cytokine staining, a single cell suspension of cells was stimulated (Janssen et al., 2017 ), stained, fixed and permeabilized as above then incubated with fluorochrome-conjugated antibodies against FOXP3, T-bet (4B10; BioLegend), IFNγ (XMG1.2; Thermo Fisher), IL-10 (JES5-16E3; BioLegend). Cell counts of skin samples were determined by addition of Precision Count Beads™ (BioLegend) to samples immediately prior to flow cytometry. A BD LSRFortessa cell analyzer with FACSDiva software (BD Biosciences, San Jose, CA) was used to collect all data which was analyzed using FlowJo v10 (Tree Star Inc., San Jose, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!